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In the developing hippocampus, fibroblast growth factor (FGF) 22 promotes the formation
of excitatory presynaptic terminals. Remarkably, FGF22 knockout (KO) mice show
resistance to generalized seizures in adults as assessed by chemical kindling, a model
that is widely used to study epileptogenesis (Terauchi et al., 2010). Repeated injections
of low dose pentylenetetrazol (PTZ) induce generalized seizures (“kindled”) in wild type
(WT) mice. With additional PTZ injections, FGF22KO mice do show moderate seizures,
but they do not kindle. Thus, analyses of how FGF22 impacts seizure susceptibility
will contribute to the better understanding of the molecular and cellular mechanisms of
epileptogenesis. To decipher the roles of FGF22 in the seizure phenotype, we examine
four pathophysiological changes in the hippocampus associated with epileptogenesis:
enhancement of dentate neurogenesis, hilar ectopic dentate granule cells (DGCs),
increase in hilar cell death, and formation of mossy fiber sprouting (MFS). Dentate
neurogenesis is enhanced, hilar ectopic DGCs appeared, and hilar cell death is increased
in PTZ-kindled WT mice relative to PBS-injected WT mice. Even in WT mice with fewer
PTZ injections, which showed only mild seizures (so were not kindled), neurogenesis,
hilar ectopic DGCs, and hilar cell death are increased, suggesting that mild seizures
are enough to induce these changes in WT mice. In contrast, PTZ-injected FGF22KO
mice do not show these changes despite having moderate seizures: neurogenesis is
rather suppressed, hilar ectopic DGCs do not appear, and hilar cell death is unchanged
in PTZ-injected FGF22KO mice relative to PBS-injected FGF22KO mice. These results
indicate that FGF22 plays important roles in controlling neurogenesis, ectopic migration
of DGCs, and hilar cell death after seizures, which may contribute to the generalized
seizure-resistant phenotype of FGF22KO mice and suggests a possibility that inhibition
of FGF22 may alleviate epileptogenesis.
Keywords: fibroblast growth factor 22, temporal lobe epilepsy, neurogenesis, hilar ectopic dentate granule cells,
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INTRODUCTION
Epilepsy is one of the most common neurological disorders,
which is characterized by recurrent seizures. Currently, the only
available pharmacological treatments for epilepsy are seizure sup-
pressants. These anticonvulsants may control seizures with vari-
ous success rates among the different forms of epilepsy. Temporal
lobe epilepsy (TLE), which is the most common type of epilepsy
in adults, is one of the most refractory epilepsies—about one-
third of patients are resistant to pharmacological treatments
(Semah et al., 1998; Brodie, 2005; French, 2007). Not only are
seizure suppressants often ineffective against intractable epilepsy,
they only address the symptoms of the disease and neither pre-
vent its initial development nor stop its progression (McNamara,
1994; Brodie, 2005; French, 2007). In order to develop effective
treatment of epilepsy, further understanding of the epileptogenic
mechanisms is required.
The hippocampus is one of the epileptogenic regions (foci)
in TLE and has been a target region for studies on cellular
mechanisms of epileptogenesis (McNamara, 1994; Morimoto
et al., 2004). Brain insults such as trauma, seizure, stroke, and
infection may cause various changes in the hippocampus, which
may eventually result in TLE (Pitkänen and Lukasiuk, 2011).
Many possible mechanisms have been proposed that might be
involved in the process of epileptogenesis (Simonato et al.,
2006; Pitkänen and Lukasiuk, 2011), including four changes in
the hippocampus that have been widely accepted to be asso-
ciated with epileptogenesis (Dudek and Sutula, 2007; Parent,
2007): (1) increased neurogenesis in the dentate gyrus (DG),
(2) hilar ectopic dentate granule cells (DGCs), (3) loss of hilar
cells (interneurons and mossy cells), and (4) formation of
mossy fiber sprouting (MFS). These changes are proposed to
be induced by brain insults, which may result in the rewiring
of the hippocampal network to establish a possible epileptic
circuitry (McNamara, 1994; Coulter, 2001; Morimoto et al.,
2004; Rakhade and Jensen, 2009; Kokaia, 2011). Increased neu-
rogenesis and hilar ectopic DGCs may contribute to abnormal
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incorporation of DGCs into the circuitry (Parent et al., 2006;
Jessberger et al., 2007; Walter et al., 2007; Kron et al., 2010),
loss of hilar cells may disrupt existing physiological balance in
the network (Dudek and Sutula, 2007; Jiao and Nadler, 2007),
and MFS, where sprouted mossy fibers form synapses onto
DGCs themselves, may induce recurrent excitation of the DGCs
(Sutula et al., 1989; Koyama and Ikegaya, 2004; Morimoto et al.,
2004). All of the four mechanisms could cause hyperexcitation
of the brain by rearranging the circuitry of the hippocam-
pus. Therefore, understanding of the molecular mechanisms
that are responsible for these epileptogenesis-associated events
may help identify possible drug targets for the treatment of
epilepsy.
Growth factors such as neurotrophins and fibroblast growth
factors (FGFs) are suggested to be involved in epileptogenesis
(Simonato et al., 2006). For example, overexpression of FGF2
increases seizure susceptibility and reduces seizure-induced cell
death (Zucchini et al., 2008). Application of BDNF and FGF2
reduces MFS and spontaneous seizures (Paradiso et al., 2009,
2011). MFS arises in the absence of FGF7 (Lee et al., 2012). Thus,
growth factors may be crucial molecules to regulate epilepto-
genesis. We have recently identified a member of FGFs, FGF22
as a molecule that organizes excitatory presynaptic differentia-
tion in the hippocampus (Umemori et al., 2004; Terauchi et al.,
2010). Remarkably, we found that FGF22 knockout (KO) mice
are resistant to generalized seizures induced by chemical kindling
with repeated injections of low dose pentylenetetrazol (PTZ), a
GABA receptor antagonist. We therefore asked whether the four
epileptogenesis-associated changes—increased DG neurogenesis,
hilar ectopic DGCs, hilar cell loss, and MFS—are induced in
the hippocampus of FGF22KO mice in response to PTZ injec-
tions, in order to get insight into the cellular basis of their
seizure-resistant phenotype. We here show that in FGF22KO
mice, these changes do not occur, even with moderate seizures
after prolonged PTZ injections. Our results suggest that inac-
tivation of FGF22 may increase resistance to epileptogenesis-
associated changes in response to seizures in the hippocampus




FGF22KO mice were described previously (Terauchi et al.,
2010). FGF22KO mice have been backcrossed with C57BL/6
for more than 15 generations. Five-month-old FGF22KO mice
and C57BL/6 mice [wild type (WT)] were used in this study.
Genotypes of the mice were verified by genomic PCR. Male mice
were used. The numbers of animals used in this study are shown
in Figure 1B. All animal use and care was in accordance with
the institutional guidelines and was approved by the University
Committee on Use and Care of Animals.
KINDLING AND ANIMAL GROUPS
PTZ (35mg/kg), a GABA receptor antagonist, was injected
intraperitoneally every 48 h in WT and FGF22KO mice to induce
seizures. Control animals received PBS. The mice were observed
for an hour after each PTZ injection, and the maximum level of
seizure within the hour was recorded. The seizure responses were
noted on a revised Racine’s scale for PTZ kindling (Lüttjohann
et al., 2009) as follows: Stage 0: No seizure observed; Stage 1:
Sudden behavioral arrest and/or motionless staring; Stage 2:
Facial jerking with muzzle or muzzle and eye; Stage 3: Neck jerks;
Stage 4: Clonic seizure in a sitting position; Stage 5: Convulsions
including clonic and/or tonic–clonic seizures while lying on the
belly and/or pure tonic seizures; Stage 6: Convulsions includ-
ing clonic and/or tonic–clonic seizures while lying on the side
and/or wild jumping. Mice were defined as “kindled” when
they displayed either one class 6 seizure or two successive class
5 seizures. We prepared three animal groups (the number of
mice in each group is shown in Figure 1B) that are differ-
ent in genotype and seizure levels for the study (see Figure 1).
Group 1: WT mice with mild seizures—WT mice were injected
until they first showed a seizure greater then level 1 (aver-
age PTZ injections = 14); Group 2: WT mice with kindled
seizures—WTmice were injected until they were kindled (average
PTZ injections = 24); Group 3: FGF22KO mice with moder-
ate seizures (not kindled)—FGF22KO mice were injected with
PTZ 37 times; the mice showed moderate seizures but did not
kindle.
BRAIN SECTIONING
The mice were perfused with 4% paraformaldehyde (PFA). The
brains were dissected and post-fixed in 4% PFA for 24 h. The
brains were then placed in 30% sucrose solution for 48 h, frozen,
and stored at −80◦C. The sections from the same region of the
hippocampus were used (4–6 sections/mouse) in this study in
order to standardize quantification of the cell numbers. Sections
between 2.5 and 3.5mm from themidline were used for the study.
Each section was 20µm thick.
IMMUNOHISTOCHEMISTRY
The sections were blocked in 2% BSA, 2% normal goat serum,
and 0.1% TritonX-100 for 30min, followed by the incubation
with primary antibodies for 2 h at room temperature. Secondary
antibodies were then applied for 1 h at room temperature, and
slides were mounted with p-phenylenediamine. Antibodies used
were: DCX (Abcam, ab18723; dilution 1:500), Ki67 (Abcam,
ab15580; dilution 1:200), Prox1 (Millipore, MAB5256; dilution
1:250), NeuN (Millipore, MAB377; dilution 1:1000), and ZnT3
(Synaptic Systems, #197002, dilution 1:200). DAPI was added to
each section as a nuclear stain. The stained sections were observed
under the Olympus BX61 fluorescent microscope. The images
were taken with the F-View Soft Imaging System camera.
NEUROGENESIS
Neurogenesis within the DGC layer was assessed using immuno-
histochemistry for doublecortin (DCX), a marker for immature
neurons, and Ki67, a marker for proliferating cells. DCX and Ki67
positive cells were counted from the entire DGC layer on a section
and divided by the total number of DGCs stained with DAPI.
HILAR ECTOPIC DGCs
Ectopic DGCs in the hilus were assessed using immunohisto-
chemistry for Prox1, a marker for DGCs. Ectopic location was
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FIGURE 1 | Characteristics of the three animal groups used in this
study: non-kindled WT mice with mild seizures, kindled WT mice,
and non-kindled FGF22KO mice with moderate seizures. WT and
FGF22KO mice were injected with a GABA receptor antagonist
pentylenetetrazol (PTZ; 35mg/kg) every 48 h to induce seizures. Control
animals received PBS. (A) Typical time course of seizure development
and three animal groups. Group 1: WT mice were injected until they first
showed a seizure greater then level 1 (∼14 PTZ injections); Group 2: WT
mice were injected until they were kindled (∼24 PTZ injections); Group
3: FGF22KO mice were injected with PTZ for 37 times—they showed
moderate seizures but did not kindle. (B) Summary of characteristics of
three animal groups. For each mouse group, the genotype, the highest
seizure level, kindled or not, the cumulative seizure score, and the
number of animals are shown. The highest seizure level indicates the
most severe seizure level observed over the entire injection period.
Group 1 mice showed only mild seizures (one level 3 seizure), Group 2
mice showed severe seizures (level 6 = kindled), and Group 3 mice
showed mild to moderate seizures (level 3–4). The cumulative seizure
score is the sum of seizure levels that the mouse has experienced
throughout the injection period. Group 1 mice received considerably less
cumulative seizures relative to Groups 2 and 3, which received
comparable amount of cumulative seizures to each other.
defined as greater than or equal to two cell body widths outside
the granule cell layer (Kron et al., 2010). The number of ectopic
Prox1-positive cells was quantified from the entire hilar region of
a hippocampal section.
HILAR CELL DEATH
Cell death in the hilus was evaluated by quantifying the number
of surviving neurons with immunohistochemistry for NeuN, a
marker for mature neurons. The number of NeuN-positive cells
was quantified from the entire hilar region of a hippocampal sec-
tion. The number of hilar ectopic DGCs was subtracted from the
number of NeuN-positive cells to evaluate hilar cell death.
MOSSY FIBER SPROUTING
MFS was examined by staining hippocampal sections for ZnT3, a
zinc transporter enriched in mossy fibers. The presence of MFS in
the inner molecular layer of the DG was examined.
RESULTS
FGF22KO MICE SHOWMODERATE SEIZURES BUT DO NOT KINDLE
WITH PROLONGED INJECTIONS OF PTZ
We have previously found that FGF22KO mice are resistant to
generalized seizures induced by PTZ kindling (Terauchi et al.,
2010), in which we injected animals with PTZ every 48 h to induce
generalized (kindled) seizures. In that experiment, when about
half of WT mice were kindled (level 6 seizure; after about 21 PTZ
injections), no FGF22KO mice were kindled. Here, we first tested
if prolonged PTZ injections can make FGF22KO mice kindled.
With additional PTZ injections, FGF22KOmice did showmild to
moderate (levels 1–4) seizures (Figure 1A). However, even after
37 PTZ injections, they did not kindle. We stopped after 37 PTZ
injections, because the cumulative seizure score (the sumof all the
seizure levels that the mouse has experienced) for the FGF22KO
mouse became ∼55 (Figure 1B), which was similar to the one for
the kindled WT mouse (∼53) (see below).
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PREPARATION OF THREE ANIMAL GROUPS TO UNDERSTAND THE
ROLE OF FGF22 IN EPILEPTOGENESIS
Since FGF22KO mice do not kindle even with prolonged PTZ
injections, we designed experiments to address the cellular basis
of their kindled seizure-resistant phenotype. We focused on four
epileptogenesis-associated changes: enhanced DG neurogenesis,
hilar ectopic DGCs, hilar cell loss, andMFS. For our experiments,
it was important to consider the possibility that the levels of these
changes may correlate with the amount of seizure overtime that
the animal experienced in response to PTZ injections. Because
FGF22KOmice do not kindle, direct comparison between kindled
WTmice and non-kindled FGF22KOmicemay not be conclusive.
Therefore, to understand the role of FGF22 in the epileptogenesis-
associated changes apart from the effects of seizure activities on
them, we injected FGF22KOmice with PTZ until their cumulative
seizure score becomes equivalent to that of kindled WT mice so
that FGF22KO mice experience similar overall amount of seizure
activity to kindled WT mice. Yet, these two groups of animals
still differ in the highest seizure level experienced (level 3–4 mod-
erate seizures for FGF22KO mice as opposed to level 6 kindled
seizures for WT mice). Thus, we prepared another group of WT
mice with only mild, non-kindled seizures. Together, we prepared
three groups of animals for our experiments (Figure 1B)—Group
1, WT mice with mild seizures (not kindled with just one level 3
seizure; cumulative seizure score = 8.4); Group 2, kindled WT
mice (with level 6 seizures; cumulative seizure score = 52.5); and
Group 3, FGF22KO mice with moderate seizures (not kindled
with up to level 4 seizures; cumulative seizure score = 55.4). By
comparing epileptogenesis-associated changes happening in these
three groups, we can evaluate the contribution of both the geno-
type and the seizures that animals experienced. For each group,
we also prepared a control group of mice, which received PBS
instead of PTZ for the same durations.
DENTATE NEUROGENESIS INCREASES IN WT MICE WITH MILD OR
KINDLED SEIZURES, BUT DECREASES IN FGF22KO MICE WITH
MODERATE SEIZURES
Enhanced neurogenesis in the DG is implicated in epileptogenesis
because it may lead to aberrant integration of DGCs (Parent et al.,
2006; Jessberger et al., 2007; Walter et al., 2007; Kron et al., 2010).
We first assessed the level of cell proliferation in the DGC layer
by staining hippocampal sections prepared from the three groups
of mice with Ki67, a marker of proliferating cells (Figure 2). The
sections from the same region of the hippocampus were used in
order to standardize quantifications of cell numbers. At the basal
level (PBS-injected mice), there was no significant difference in
the number of Ki67-positive cells in the DG between WT and
FGF22KO mice (Figure 2B). The number of Ki67-positive cells
was increased in kindled WT mice relative to PBS-injected con-
trols. It was increased more dramatically in non-kindledWTmice
with mild seizures, suggesting that mild seizures enhance cell pro-
liferation in the DG in WT mice. In contrast, FGF22KO mice
showed a decrease in the number of Ki67-positive cells in the
DG when injected with PTZ, despite having moderate seizures
(Figure 2).
Similar but slightly different results were observed with stain-
ing for DCX, a marker of immature neurons (Figure 3). At the
FIGURE 2 | The number of proliferating cells in the DG increases in
WT mice but decreases in FGF22KO mice upon PTZ injections.
Region-matched sagittal hippocampal sections were prepared from PBS-
and PTZ-injected WT and FGF22KO mice (3 groups of mice as shown in
Figure 1) and stained for Ki67, a marker for proliferating cells. (A) Ki67
positive cells (pink) with DAPI (blue) in the DG of PBS- or PTZ-injected WT
and FGF22KO mice. (B) Quantification of the numbers of Ki67-positive cells
in the DGC layer per section in PBS-injected WT and FGF22KO mice (n.s. =
not significant). (C) Quantification of the percentages of Ki67-positive cells
in DGCs. Data are normalized against corresponding PBS controls. The
percentage of Ki67-positive cells was significantly increased in WT mice
with mild and kindled seizures, but was decreased in FGF22KO mice with
moderate seizures upon PTZ-injections. Bars are mean ± s.e.m. Data are
from 4–6 sections from 3–10 mice (see Figure 1B) per each condition.
Student’s t-test P -values are indicated.
basal level (PBS-injected mice), we found less DCX-positive cells
in the DG in FGF22KO mice than in WT mice (Figure 3B), sug-
gesting that FGF22 is involved in neuronal differentiation. The
number of DCX-positive cells was increased inWTmice with kin-
dled seizures, which is consistent with previous reports (Parent
et al., 2006; Jessberger et al., 2007; Yin et al., 2007; Buga et al.,
2012). It was similarly increased in WT mice with mild seizures.
These, together with the Ki67 results suggest that seizures induce
neurogenesis, but mild seizures affect more on proliferation than
kindled seizures do. In contrast, the number of DCX-positive cells
was decreased in FGF22KO mice with moderate seizures. These
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FIGURE 3 | The number of immature neurons in the DG is increased in
WT mice with mild and kindled seizures, but is decreased in FGF22KO
mice with moderate seizures. Region-matched sagittal hippocampal
sections were prepared from PBS- and PTZ-injected WT and FGF22KO
mice (3 groups of mice as shown in Figure 1) and stained for doublecortin
(DCX), a marker for immature neurons. (A) DCX positive cells (green) with
DAPI (blue) in the DG of PBS- or PTZ-injected mice. (B) Quantification of
the numbers of DCX-positive cells in the DGC layer per section in
PBS-injected WT and FGF22KO mice. (C) Quantification of the percentages
of DCX-positive cells in DGCs. Data are normalized against corresponding
PBS controls. Neurogenesis, as reflected by the percentage of
DCX-positive cells, was significantly increased in WT mice with mild and
kindled seizures, but was decreased in FGF22KO mice with moderate
seizures upon PTZ-injections. Bars are mean ± s.e.m. Student’s t-test
P -values are indicated.
results suggest that FGF22 is involved in seizure-induced increases
in neurogenesis in the DG.
HILAR ECTOPIC DGCs APPEAR INWT MICE WITH MILD OR KINDLED
SEIZURES, BUT NOT IN FGF22KO MICE WITH MODERATE SEIZURES
Hilar ectopic DGCs may lead to aberrant integration of DGCs
and contribute to epileptogenesis (Parent et al., 2006; Jessberger
et al., 2007; Walter et al., 2007; Kron et al., 2010). We next
examined the number of hilar ectopic DGCs by staining hip-
pocampal sections for Prox1, a marker of DGCs (Figure 4). There
was no hilar ectopic DGC in the basal condition (PBS injected)
in both WT and FGF22KO mice. The number of hilar ectopic
FIGURE 4 | The number of hilar ectopic DGCs is increased in WT mice
with mild and kindled seizures, but not in FGF22KO mice with
moderate seizures. Region-matched sagittal hippocampal sections were
prepared from PBS- and PTZ-injected WT and FGF22KO mice (3 groups of
mice as shown in Figure 1) and stained for Prox1, a marker for DGCs.
Ectopic location was defined as greater than or equal to two cell body
widths outside the granule cell layer. (A) Prox1 positive cells in the DG and
hilus of PBS- or PTZ-injected mice. (B) Quantification of the numbers of
ectopic Prox1-positive cells in the hilus. The number of hilar ectopic DGCs
was significantly increased in WT mice with mild and kindled seizures, but
not in FGF22KO mice with moderate seizures upon PTZ-injections. Bars are
mean ± s.e.m. Student’s t-test P -values are indicated.
DGCs dramatically increased in WT mice with kindled seizures
(Figure 4B). It was also substantially increased in WT mice with
mild seizures. However, there was no significant increase in
FGF22KOmice with moderate seizures. These results suggest that
FGF22 is involved in ectopic migration of DGCs in response to
seizures.
HILAR CELL DEATH INCREASES INWT MICE WITH MILD OR KINDLED
SEIZURES, BUT IS UNCHANGED IN FGF22KO MICE WITH MODERATE
SEIZURES
An increase in hilar cell death is another change that is asso-
ciated with epileptogenesis (Dudek and Sutula, 2007; Jiao and
Nadler, 2007). We next evaluated the level of hilar cell death in
PTZ-injected WT and FGF22KO mice by quantifying the num-
ber of surviving mature neurons in the hilar region with NeuN
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FIGURE 5 | Hilar cell death is increased in WT mice with mild and
kindled seizures, but is unchanged in FGF22KO mice with moderate
seizures. Region-matched sagittal hippocampal sections were prepared
from PBS- and PTZ-injected WT and FGF22KO mice (3 groups of mice as
shown in Figure 1) and stained for NeuN, a marker for mature neurons.
(A) NeuN staining of the hilar sections from PBS- or PTZ-injected mice.
(B) Quantification of the numbers of NeuN-positive cells in the hilus per
section in PBS-injected WT and FGF22KO mice. (C) Quantification of the
numbers of hilar cells. To evaluate hilar cell number, the number of hilar
ectopic DGCs (Figure 4) was subtracted from the number of NeuN-positive
cells. Data are normalized relative to the corresponding PBS control. After
PTZ injections, the number of hilar cells significantly decreased in WT mice
both with mild and with kindled seizures, but not in FGF22KO mice with
moderate seizures. Bars are mean ± s.e.m. P -values by Student’s t-test are
indicated.
staining (Figure 5). We have calculated the number of hilar cells
by subtracting the number of hilar ectopic DGCs (Figure 4) from
the number of NeuN-positive cells. The number of hilar cells
was decreased in kindled WT mice relative to PBS-injected mice,
which is consistent with previous reports (Sloviter, 1983; Dudek
and Sutula, 2007; Jiao and Nadler, 2007; Naseer et al., 2013). It
was also decreased in non-kindled WT mice with mild seizures,
suggesting that similar to the case of neurogenesis (Figures 2, 3),
mild seizures are enough to increase hilar cell death in WT mice.
However, the number of hilar cells was not significantly changed
FIGURE 6 | MFS is only induced in kindled WT mice. Region-matched
sagittal hippocampal sections were prepared from PBS- and PTZ-injected
WT and FGF22KO mice (3 groups of mice as shown in Figure 1) and
stained for ZnT3, a zinc transporter enriched in mossy fiber terminals, to
examine MFS in the DG. Kindled WT mice show MFS in the dentate
molecular layer (arrows), while non-kindled WT and FGF22KO mice do not.
in PTZ-injected FGF22KO mice with moderate seizures rela-
tive to PBS-injected controls. These results suggest that FGF22
plays important roles in increasing hilar cell death in response to
seizures.
MFS IS INDUCED ONLY IN KINDLED WT MICE
In TLE patients and animal models of TLE, mossy fibers (axons
of DGCs) often abnormally sprout to the dentate molecular layer
and form excitatory synapses with the dendrites of DGCs (MFS).
Accordingly, MFS may induce recurrent excitation of DGCs and
contribute to epileptogenesis. We next examined whether WT
and FGF22KO mice display MFS after seizures. To examine MFS,
we stained DG sections with ZnT3, a zinc transporter that is
abundant in mossy fiber terminals (Wenzel et al., 1997). MFS
in the dentate molecular layer was detected in kindled WT mice
(Figure 6), as observed previously with Timm staining (Sutula
et al., 1989; Cavazos et al., 1991; Parent et al., 1999). In con-
trast, MFS was not detected in non-kindled WT mice with mild
seizures, suggesting that more severe or prolonged seizures may
be required to form MFS in WT mice. MFS was not observed in
FGF22KO mice with moderate seizures either. This implies that
either FGF22 is required for the formation of MFS or that more
severe seizures are necessary to induce MFS.
DISCUSSION
FGF22KO mice are more resistant to generalized seizures than
WT mice as assessed by PTZ kindling (Terauchi et al., 2010).
Here we addressed the possible cellular basis for the phenotype
by focusing on four changes in the hippocampus associated with
epileptogenesis: enhancement of dentate neurogenesis, appear-
ance of hilar ectopic DGCs, increase in hilar cell death, and
formation of MFS. These changes were indeed observed in kin-
dled WT mice. Even in non-kindled WT mice with only mild
seizures, three changes, enhanced neurogenesis, hilar ectopic
DGCs, and increased hilar cell death, occurred. In contrast, PTZ-
injected FGF22KO mice did not show any of these four changes,
despite having moderate seizures after prolonged injections of
PTZ. From these results, we conclude that FGF22 plays critical
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roles in increasing neurogenesis, ectopic DGCs, and hilar cell
death in response to seizures. As for MFS, since MFS was not
detected in WT mice with mild seizures either, we conclude that
either FGF22 is involved in the formation of MFS or that more
severe seizures are necessary to induce MFS. Our results suggest
that inhibition of FGF22 suppresses neurogenesis, hilar ectopic
DGCs, and hilar cell death (and possibly MFS) in response to
seizures.
Since FGF22KO mice did show moderate seizures in our
experiments, suppression of epileptogenesis-associated changes
in FGF22KO mice is not due to lack of seizures, but rather due
to FGF22-deficiency. Thus, our results indicate that FGF22 is
involved in seizure activity-induced modifications in the hip-
pocampus. We have previously shown that FGF22 from CA3
pyramidal neurons promotes the organization of excitatory
synapses formed onto them (Terauchi et al., 2010). FGF22 from
CA3 may also send signals to DGCs to regulate neurogen-
esis and hilar cell survival in an activity-dependent manner.
FGF22-dependent signals may induce other growth factors, neu-
rotrophins, morphogens, and cytokines that are implicated in
dentate neurogenesis and cell survival (Simonato et al., 2006;
Parent, 2007; Zhao et al., 2008). We are currently indentify-
ing FGF22 receptors and downstream signals mediating these
epileptogenesis-associated changes using FGF receptor mutants
and are analyzing the roles of FGF22-target genes in dentate
neurogenesis.
Another interesting finding is that in FGF22KO mice
with moderate seizures, neurogenesis is decreased, rather than
unchanged as was seen in the case of hilar cell death. One
possible interpretation for this finding is that seizure activities
might eventually be generating two signals, positive signals result-
ing in reactive neurogenesis and negative signals for negative-
feedback/homeostatic-control, to regulate dentate neurogenesis
and that FGF22 is preferentially involved in the positive signals.
Further analysis should reveal the activity-dependent signaling
pathways that regulate neurogenesis.
Most importantly, our results suggest a possibility that FGF22
inactivation could suppress the enhancement of neurogenesis,
ectopic DGCs, and hilar cell death (and possiblyMFS) in response
to seizures. Thus, FGF22 may join FGF2 as the FGFs that are
involved in epileptogenesis or epileptogenesis-associated changes.
It has been shown that aberrant adult-born DGCs can cause
epilepsy (Pun et al., 2012), hilar cell death causes DGC hyper-
excitability (Jinde et al., 2012), and MFS is likely to contribute
to seizure susceptibility (Morgan et al., 2007). Thus, targeting
FGF22 could offer a novel strategy to prevent epileptogenesis or
epileptogenesis-associated changes. For this reason, we are cur-
rently performing small molecule screening for FGF22 inhibitors,
hoping to identify candidate drugs to treat or alleviate TLE.
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